TABLE 4.
Author | IP Test | Type analysis | Group | Association between IP and clinical variable |
---|---|---|---|---|
Hendy et al | Serum Zonulin | Pearson correlation | 56 NAFLD | BMI (r = .378), ALT (r = .312), triglycerides (r = .296), HDL‐C (r = −.397), HOMA‐IR (r = .413), serum IL‐6 (r = .288). |
Pacifico et al | Serum Zonulin | linear regression adjusted for age, gender and pubertal status |
Total group ‐ 40 HC ‐ 40 NAFLD |
‐ γ‐GT (β = 0.229), 2 h insulin (β = 0.340), WIBSI (β = −0.236) |
Guercio Nuzio et al | L/M (5 h) | Pearson correlation |
Total group ‐ 11 NAFLD ‐ 21 HC |
Serum LPS (r = .48) |
Nobili et al | L/M (5h) | Univariable linear regression | 80 NAFLD | Systolic blood pressure (β = 0.196), Plasma LPS (β = 0.296). |
Abbreviations: L/M, lactulose mannitol ratio; NAFLD, nonalcoholic fatty liver disease; HC, healthy control, BMI, body mass index; HDL‐C, high density lipoprotein cholesterol; ALT, alanine transaminase; HOMA‐IR, homeostasis model of assessment‐insulin resistance; γ‐GTP, gamma‐glutamyl transpeptidase; WIBSI, whole body insulin sensitivity; LPS, lipopolysaccharide.